Clinical Trial Update: Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

View source ↗

Summary

A completed observational study evaluating how physicians decide on treatment for patients with rheumatoid arthritis treated with tofacitinib. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2024-10-21